Form 9 - Notice of Proposed Issuance of Listed Securities
{00044518:2}
FORM 9
NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED
SECURITIES
(or securities convertible or exchangeable into listed securities1)
Name of Listed Issuer: Symbol(s):
Blast Resources Inc. (the “Issuer”). BLST
Date: August 1, 2024
Is this an updating or amending Notice: Yes X No
If yes provide date(s) of prior Notices: ________________________.
Issued and Outstanding Securities of Issuer Prior to Issuance: 13,536,864.
Pricing
Date of news release announcing proposed issuance: July 30, 2024
Date of confidential request for price protection: N/A
Closing Market Price on Day Preceding the news release: $0.05
Day preceding request for price protection: N/A
Closing
Number of securities to be issued: Unsecured Convertible Debentures for Principal
Amount of up to $150,000
Issued and outstanding securities following issuance: Up to 16,536,864 based on the
issued and outstanding number of shares of the Issuer as at the date hereof and provided
no additional shares of the Issuer are issued between the date hereof and the conversion
of the Debentures (defined below), other than the conversion of the Debentures as set
out herein.
Instructions:
1. For private placements (including debt settlement), complete tables 1A and 1B in
Part 1 of this form.
2. Complete Table 1A – Summary for all purchasers, excluding those identified in Item
8.
3. Complete Table 1B – Related Persons only for Related Persons
4. If shares are being issued in connection with an acquisition (either as consideration
or to raise funds for a cash acquisition) please proceed to Part 2 of this form.
5. An issuance of non-convertible debt does not have to be reported unless it is a
significant transaction as defined in Policy 7, in which case it is to be reported on
Form 10 – Notice of Proposed Transaction
{00044518:2}
6. Post the completed Form 9 to the CSE website in accordance with Policy 6 –
Distributions. In addition, the completed form must be delivered to
[email protected] with an appendix that includes the information in Table 1B for
ALL placees.
{00044518:2}
Part 1. Private Placement
Table 1A – Summary
Each jurisdiction in which
purchasers reside
Number of
Purchasers
Price per
Security
Total dollar value
(CDN$) raised in
the jurisdiction
To Follow
Total number of purchasers:
Total dollar value of distribution in all jurisdictions:
Table 1B – Related Persons
Full Name
&Municipali
ty of
Residence
of Placee
Number of
Securities
Purchased
or to be
Purchased
Purchase
price per
Security
(CDN$)
Conversion
Price (if
Applicable)
(CDN$)
Prospectus
Exemption
Total Securities
Previously
Owned,
Controlled or
Directed
Payment
Date(1)
Describe
relations
-hip to
Issuer (2)
To be
determined
1An issuance of non-convertible debt does not have to be reported unless it is a significant transaction as
defined in Policy 7, in which case it is to be reported on Form 10.
1. Total amount of funds to be raised: up to $150,000 .
2. Provide full details of the use of the proceeds. The disclosure should be
sufficiently complete to enable a reader to appreciate the significance of the
transaction without reference to any other material. Use of proceeds will be
for general working capital and corporate purposes.
3. Provide particulars of any proceeds which are to be paid to Related Persons
of the Issuer: N/A
.
4. If securities are issued in forgiveness of indebtedness, provide details of the
debt agreement(s) or and the agreement to exchange the debt for securities.
5. Description of securities to be issued:
{00044518:2}
(a) Class Common shares
(b) Number Up to 3,000,000 common shares upon conversion
(c) Price per security See Conversion Price below
(d) Voting rights One vote for each common share issued
6. Provide the following information if warrants, (options) or other convertible
securities are to be issued:
(a) Number N/A .
(b) Number of securities eligible to be purchased on exercise of
warrants (or options) N/A
(c) Exercise price N/A
(d) Expiry date N/A .
7. Provide the following information if debt securities are to be issued: Non-
transferrable unsecured convertible debentures (the “Debentures”)
(a) Aggregate principal amount Up to $150,000 .
(b) Maturity date 6 months from date of issuance .
(c) Interest rate Nil .
(d) Conversion terms Upon the completion by the Issuer of an equity
arm’s length financing(s) for minimum aggregate gross proceeds of
$600,000 and so long as all or a part of the principal amount remains
outstanding under the Debentures, the holder will have the right, at
its option, to convert all or any part of the principal amount into
common shares of the Company at a price of $0.05 per Share
(e) Default provisions Customary default provisions including failure to
pay principal amount when due for more than 30 days when due,
cessation to carry on business, bankruptcy or insolvency of the
Issuer, dissolution, winding-up or liquidation of the Issuer.
8. Provide the following information for any agent’s fee, commission, bonus or
finder’s fee, or other compensation paid or to be paid in connection with the
placement (including warrants, options, etc.):
(a) Details of any dealer, agent, broker or other person receiving
compensation in connection with the placement (name , and i f a
corporation, identify persons owning or exercising voting control over
20% or more of the voting shares if known to the Issuer): None
anticipated at this time.
{00044518:2}
(b) Cash ______________________________________________.
(c) Securities ___________________________________________.
(d) Other _______________________________________________.
(e) Expiry date of any options, warrants etc. ____________________ .
(f) Exercise price of any options, warrants etc. _____________ .
9. State whether the sales agent, broker, dealer or other person receiving
compensation in connection with the placement is Related Person or has any
other relationship with the Issuer and provide details of the relationship
N/A .
10. Describe any unusual particulars of the transaction (i.e. tax “flow through”
shares, etc.).
N/A .
11. State whether the private placement will result in a change of control or if the
issuance will materially affect control of the Issuer.
N/A .
12. Where there is a change in the control of the Issuer resulting from the issuance
of the private placement shares, indicate the names of the new controlling
shareholders. N/A
.
13. Each purchaser has been advised of the applicable securities legislation
restricted or seasoning period. All certificates for securities issued which are
subject to a hold period bear the appropriate legend restricting their transfer
until the expiry of t he applicable hold period required by National Instrument
45-102 Resale of Securities.
{00044518:2}
Part 2. Acquisition
1. Provide details of the assets to be acquired by the Issuer (including the location
of the assets, if applicable). The disclosure should be sufficiently complete to
enable a reader to appreciate the significance of the transaction without
reference to any other material:
.
2. Provide details of the acquisition including the date, parties to and type of
agreement (eg: sale, option, license etc.) and relationship to the Issuer. The
disclosure should be sufficiently complete to enable a reader to appreciate the
significance of the acquisition without reference to any other material:
3. Provide the following information in relation to the total consideration for the
acquisition (including details of all cash, securities or other consideration) and
any required work commitments:
(a) Total aggregate consideration in Canadian dollars: .
(b) Cash: .
(c) Securities (including options, warrants etc.) and dollar value:
.
(d) Other: .
(e) Expiry date of options, warrants, etc. if any: .
(f) Exercise price of options, warrants, etc. if any: .
(g) Work commitments: .
4. State how the purchase or sale price was determined (e.g. arm’s-length
negotiation, independent committee of the Board, third party valuation etc).
5. Provide details of any appraisal or valuation of the subject of the acquisition
known to management of the Issuer:
.
6. The names of parties receiving securities of the Issuer pursuant to the
acquisition and the number of securities to be issued are described as follows:
{00044518:2}
Name of
Party (If not
an
individual,
name all
insiders of
the Party)
Number
and Type
of
Securities
to be
Issued
Dollar
value per
Security
(CDN$)
Conversion
price (if
applicable)
Prospectus
Exemption
Total
Securities,
Previously
Owned,
Controlled or
Directed by
Party
Describe
relationship
to Issuer(1)
(1) Indicate if Related Person
7. Details of the steps taken by the Issuer to ensure that the vendor has good title
to the assets being acquired:
.
8. Provide the following information for any agent’s fee, commission, bonus or
finder’s fee, or other compensation paid or to be paid in connection with the
acquisition (including warrants, options, etc.):
(a) Details of any dealer, agent, broker or other person receiving
compensation in connection with the acquisition (name, andif a
corporation, identify persons owning or exercising voting control over
20% or more of the voting shares if known to the Issuer):
.
(b) Cash .
(c) Securities .
(d) Other .
(e) Expiry date of any options, warrants etc.
(f) Exercise price of any options, warrants etc. .
9. State whether the sales agent, broker or other person receiving compensation
in connection with the acquisition is a Related Person or has any other
relationship with the Issuer and provide details of the relationship.
10. If applicable, indicate whether the acquisition is the acquisition of an interest in
property contiguous to or otherwise related to any other asset acquired in the
last 12 months.
{00044518:2}
Certificate Of Compliance
The undersigned hereby certifies that:
1. The undersigned is a director and/or senior officer of the Issuer and has been
duly authorized by a resolution of the board of directors of the Issuer to sign
this Certificate of Compliance on behalf of the Issuer.
2. As of the date hereof there is not material information concerning the Issuer
which has not been publicly disclosed.
3. the Issuer has obtained the express written consent of each applicable
individual to:
(a) the disclosure of their information to the Exchange pursuant to this Form
or otherwise pursuant to this filing; and
(b) the collection, use and disclosure of their information by the Exchange in
the manner and for the purposes described in Appendix A or as otherwise
identified by the Exchange, from time to time
4. The undersigned hereby certifies to the Exchange that the Issuer is in
compliance with the requirements of applicable securities legislation (as such
term is defined in National Instrument 14-101) and all Exchange Requirements
(as defined in CSE Policy 1).
5. All of the information in this Form 9 Notice of Issuance of Securities is true.
Dated August 1, 2024
Gary Claytens
Name of Director or Senior
Officer
“Gary Claytens”
Signature
CEO
Official Capacity